Elizabeth Hamburg (Chair, Mentor Advisory Group)

Kate Hartnick Elliott ’90

Kate Hartnick Elliott is the president of Hartnick Consulting (www.hartnickconsulting.com), a boutique marketing consultancy that provides strategy, PR and other communications, online marketing and training solutions to a clientele that includes Working Mother Media, United Jewish Communities, Seedco, Picture Projects, The New School, Clarins USA, and Carnegie Corporation of New York. A well-known expert on marketing, Elliott has recently spoken on the topic at the business schools of Columbia and Vanderbilt, at The New School, for a group of Seedco Nonprofit Venture Network grantees, at a Carnegie Corporation Workshop on strategic marketing communications, at the Support Center for Nonprofit Management and at a national United Jewish Communities/The Federations of North America's Marketing Planning Group meeting.

In addition to her MBA from Columbia Business School, Elliott received her BA, magna cum laude, from Amherst College.

 Joan Helpern

Joan Helpern is the former president, CEO, designer and creative director for Joan & David, the well-known, ready-to-wear footwear and accessories line for women founded in 1968. Among many honors, Ms. Helpern has received fashion awards from Coy, Michaelangelo and the Footwear Hall of Fame. She has been named to the “Working Woman 50,” the “Working Woman 500” and the Leading Women Entrepreneurs of the World™. Recognized as a role model, she was presented with the Athena Award by Hunter College and the “Shattered Ceiling Award” (Atlanta, Ga.). She is also a founding member of the Committee of 200. Having sold Joan and David at the end of 2000, she now has commitments to Rockefeller University and Women in Science and to the Kennedy School of Government at Harvard University (with emphasis on “Women Waging Peace”).
Jeffrey Hoffman
Jeffrey Hoffman is partner at Swidler Berlin Shereff Friedman, LLP, where he practices primarily in the areas of corporate and securities law, with specialties in mergers and acquisitions, public and private financings, and venture capital. Mr. Hoffman is a frequent speaker and panelist on programs that focus on corporate and financial matters. He has served as chairman of numerous programs sponsored by the Practicing Law Institute as well as other organizations and was a contributing editor and cochairman of Understanding the Securities Law, published by PLI in 1994.
Mr. Hoffman has a BA from Harvard University and an LLB from Columbia Law School.

Tim Howe ’85

Tim Howe is founding partner and founding member of Collinson Howe & Lennox. He has been investing in private equities since 1984 and has been responsible for a number of investments in the biotechnology, medical device and services areas. Prior to the founding of Collinson Howe & Lennox, Mr. Howe was a partner at Schroder Ventures investing in a range of industries in addition to health care. He also played a leading role in the formation of Biotechnology Investment Group, LLC, which was organized in 1995 to take over the management of a pre-existing portfolio of public and private health care companies at various stages of development. Mr. Howe has been a director of numerous private and public firms and currently serves on the boards of four companies: Bionaut Pharmaceuticals, Inc., Comprehensive NeuroScience, Inc., Revivant, Inc., and RxCentric, Inc. As an adjunct professor at Columbia Business School, he teaches venture capital management.

Mr. Howe received a BA from Columbia University.

Liz Ingrassia

Liz Ingrassia teaches the Columbia Business School class Launching New Ventures and also is CEO of Harvard Management Group, Inc., a consulting firm specializing in writing business plans, content and product development, marketing, branding and strategy. Ms. Ingrassia has founded several companies, the most recent being eLuxury.com, an Internet site funded by several prominent venture capitalists and LVMH. Prior to founding eLuxury, Ms. Ingrassia worked for Time Warner and SNET in their respective interactive television and multimedia divisions.

Andrew Jacobs ’96

As an officer of Angelo, Gordon & Co., Andrew Jacobs undertakes acquisition and asset management responsibilities for a diversified portfolio, currently consisting of 35 properties located throughout the United States. Angelo Gordon is a New York money manager with approximately $8 billion invested in several alternative investment strategies. The real estate group focuses on buying and repositioning subperforming properties and loans. Prior to working at Angelo Gordon, Mr. Jacobs was a project manager for Hines, where he oversaw the development of a Westin hotel and the disposition of a large portfolio of industrial properties. Before Hines, Mr. Jacobs worked for Campbell Soup, selling surplus industrial properties and selecting retail locations for Campbell's subsidiary, Godiva Chocolatier.

In addition to his MBA in real estate finance from Columbia Business School, he holds a BS in the history of art from the University of Pennsylvania.

Scott Johnson ’97

Mr. Johnson is the founder and CEO of SJ Partners LLC (SJP), an investment banking boutique that provides financial advisory and capital raising services primarily to domestic and foreign media, consumer, information technology and real estate firms. SJP’s advisory work encompasses mergers and acquisition counsel as well as analysis of overall financial strategy and capital structure. Mr. Johnson was a member of Institutional Investor–rated teams at both Salomon Smith Barney and Merrill Lynch (with the Merrill team rated #2 on Wall Street by Institutional Investor). Notable transactions completed at Salomon include the $900 million acquisition of Carson, Pirie Scott by Proffitts, Inc., and the $3.3 billion acquisition of Saks Fifth Avenue by Saks Incorporated. At Merrill, transactions included the landmark $89 billion acquisition of Warner Lambert by Pfizer and secondary equity offerings by Gillette, Inc., and the Estée Lauder Companies. Mr. Johnson complements his financial orientation with operating experience, having served as CFO of an early-stage media company.

In addition to his MBA, he has a BA and an MIA from Columbia University.
Daniel Jones ‘66
Daniel Jones is the founder, president and CEO of Newsbank, Inc., a leading electronic publisher of current and historical primary-source information for schools, universities and public libraries worldwide. Prior to founding Newsbank in 1972, Mr. Jones was an associate at Knight, Gladieux & Smith, a management consulting company. He also served as executive vice president and chief operating officer at Text Communication Corp., which pioneered the development of word processing technology. He is founder of Columbia Naples Capital, LLG, a private equity firm specializing in management buyouts and leverage acquisitions. He founded and currently sits on the board of New Canaan Bank and Trust Company in New Canaan, Conn. He also served as a lieutenant in the U.S. Navy Supply Corps.
In addition to his MBA from Columbia Business School, he holds a BA from Northwestern University.
Sharon Joseph ’97

Sharon Joseph has more than ten years of experience in banking and consulting. Upon graduation from Columbia, she went to work for Booz Allen & Hamilton in the financial service group. Later, she worked at Donaldson, Lufkin & Jenrette in the private client group. She is currently working on opening a 50,000–sq. ft. bowling and family entertainment complex in Harlem, where she grew up. The business is part of the Clinton Small Business Initiative. Ms. Joseph is very active in the alumni networks at both Columbia and Tufts.

In addition to her MBA from Columbia Business School, she holds a degree in international relations from Tufts University.
Richard Juelis ’73
After graduating from the Business School, Richard Juelis worked with three major pharmaceutical companies for over 15 years. He spent seven years with Hoffman-LaRoche in financial and business consulting positions supporting their diverse operating division in the United States. In the 198s, Juelis joined Schering-Plough, spending three years in Puerto Rico as finance director for several of their pharmaceutical manufacturing facilities. After Puerto Rico, he became general manager for Schering's biotechnology subsidiary in Ireland. The Irish operation is now among the top three biotechnology production centers in the world. He has been chief financial officer at three early-stage companies, including his current company, Cellegy Pharmaceuticals. Cellegy is a drug-delivery and dermatology company that went public several years ago. The company is launching a spin-off to sell “cosmeceuticals,” including a line of anti-wrinkle products.

Directory: rtfiles
rtfiles -> The Really Smart Phone

Download 137.36 Kb.

Share with your friends: